Ethic Inc. Gilead Sciences, Inc. Transaction History

Ethic Inc.

$5.89 Billion
Q3 2025

A detailed history of Ethic Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ethic Inc. holds 77,016 shares of GILD stock, worth $9.56 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

77,016

Previous 75,093 2.56%

Holding current value

$9.56 Million

Previous $8.33 Million 2.68%

% of portfolio

0.15%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 17, 2025	BUY	$108.22 - $120.47 $208,107 - $231,663	1,923 Added 2.56%	77,016 $8.55 Million
Q2 2025 Jul 30, 2025	BUY	$96.91 - $113.0 $370,293 - $431,773	3,821 Added 5.36%	75,093 $8.33 Million
Q1 2025 May 13, 2025	SELL	$89.14 - $117.41 $2.97 Million - $3.92 Million	-33,372 Reduced 31.89%	71,272 $7.99 Million
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $641,210 - $747,760	7,638 Added 7.87%	104,644 $9.67 Million
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $498,226 - $628,413	7,482 Added 8.36%	97,006 $8.13 Million

Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $472,488 - $545,288	-7,482 Reduced 7.71%	89,524 $6.14 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $1.13 Million - $1.38 Million	-15,772 Reduced 13.98%	97,006 $7.11 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $324,073 - $367,507	4,423 Added 4.08%	112,778 $9.14 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $555,141 - $605,670	7,508 Added 7.44%	108,355 $8.12 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $441,466 - $503,553	5,808 Added 6.11%	100,847 $7.77 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $2.41 Million - $2.74 Million	31,117 Added 48.68%	95,039 $7.89 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.19 Million - $1.7 Million	19,028 Added 42.38%	63,922 $5.49 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $832,309 - $950,711	13,979 Added 45.22%	44,894 $2.77 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $224,819 - $253,213	3,895 Added 14.42%	30,915 $1.91 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $210,017 - $263,175	-3,626 Reduced 11.83%	27,020 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $809,507 - $918,806	-12,477 Reduced 28.93%	30,646 $2.23 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $452,846 - $488,570	-6,690 Reduced 13.43%	43,123 $3.01 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $1.01 Million - $1.11 Million	15,969 Added 47.18%	49,813 $3.43 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $874,020 - $997,256	14,567 Added 75.57%	33,844 $2.19 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $250,336 - $285,246	4,419 Added 29.74%	19,277 $1.12 Million
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $234,241 - $294,517	3,772 Added 34.02%	14,858 $939,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $104,603 - $121,464	1,446 Added 15.0%	11,086 $853,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $117,619 - $150,653	1,878 Added 24.19%	9,640 $721,000
Q4 2019 May 22, 2020	BUY	$61.62 - $67.78 $985 - $1,084	16 Added 0.21%	7,762 $504,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $477,308 - $525,023	7,746 New	7,746 $503,000

Others Institutions Holding GILD

# of Institutions

2,369

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account